logo
搜索
菜单

的搜索结果

当前374/740页
排序: 最近更新
10.5: In Vitro Drug Dissolution: Alternative Methods 01:17 min
10.5: In Vitro Drug Dissolution: Alternative Methods
10.4: In Vitro Drug Dissolution: Compendial Testing Models II 01:09 min
10.4: In Vitro Drug Dissolution: Compendial Testing Models II
10.3: In Vitro Drug Dissolution: Compendial Testing Models I 01:13 min
10.3: In Vitro Drug Dissolution: Compendial Testing Models I
10.2: In Vitro Drug Release Testing: Overview, Development and Validation 01:10 min
10.2: In Vitro Drug Release Testing: Overview, Development and Validation
10.1: Biopharmaceutical Factors Influencing Drug Product Design: Overview 01:22 min
10.1: Biopharmaceutical Factors Influencing Drug Product Design: Overview
9.17: Drug Products: Biologics, Biosimilars and Interchangeables 01:28 min
9.17: Drug Products: Biologics, Biosimilars and Interchangeables
9.16: Bioequivalence Data: Statistical Interpretation 01:16 min
9.16: Bioequivalence Data: Statistical Interpretation
9.15: Bioequivalence studies: Biowaivers 01:13 min
9.15: Bioequivalence studies: Biowaivers
9.14: Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs 01:15 min
9.14: Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
9.13: Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs 01:20 min
9.13: Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
9.12: Equivalence: In Vitro and In Vivo Bioequivalence 01:17 min
9.12: Equivalence: In Vitro and In Vivo Bioequivalence
9.11: Bioavailability Enhancement: Drug Stability Enhancement and GI Retention 01:05 min
9.11: Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
9.10: Bioavailability Enhancement: Drug Permeability Enhancement 01:27 min
9.10: Bioavailability Enhancement: Drug Permeability Enhancement
9.9: Bioavailability Enhancement: Drug Solubility Enhancement 01:16 min
9.9: Bioavailability Enhancement: Drug Solubility Enhancement
9.8: Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems 01:22 min
9.8: Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
9.7: Measurement of Bioavailability: Pharmacodynamic Methods 01:20 min
9.7: Measurement of Bioavailability: Pharmacodynamic Methods
9.6: Measurement of Bioavailability: Pharmacokinetic Methods 01:30 min
9.6: Measurement of Bioavailability: Pharmacokinetic Methods
9.5: Bioavailability Study Design: Healthy Subjects Versus Patients 01:15 min
9.5: Bioavailability Study Design: Healthy Subjects Versus Patients
9.4: Bioavailability Study Design: Single Versus Multiple Dose Studies 01:11 min
9.4: Bioavailability Study Design: Single Versus Multiple Dose Studies
9.3: Bioavailability Study Design: Absolute Versus Relative Bioavailability 01:27 min
9.3: Bioavailability Study Design: Absolute Versus Relative Bioavailability
返回顶部